Open access
1,783
Views
5
CrossRef citations to date
0
Altmetric
Research Papers
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
Guillermo M. Ruiz-PalaciosDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, C.P. México City, México
, Geert Leroux-RoelsCentre for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium
, Jiri BeranVaccination and Travel Medicine Centre, Hradec Kralove, Czech Republic; and 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
, Jeanne-Marie DevasterJeanne-Marie Devaster, MD, GSK Vaccines, Rixensart, Belgium
, Meral EsenInstitut für Tropenmedizin, Tübingen, Germany
, Odile LaunayInserm, CIC 1417 and French Network of Clinical Investigation in Vaccinology (I-REIVAC), France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, CIC Cochin Pasteur, Paris, France
, Janet E. McElhaneyHSN Volunteer Association Chair in Geriatric Research, Health Sciences North Research Institute, Sudbury, ON, Canada
, Gerrit A. van EssenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
, Anne BenoitInstitute of Statistics, Biostatistics and Actuarial Sciences, Université Catholique de Louvain, Louvain-la-Neuve, Belgium
, Carine ClaeysGSK Vaccines, Wavre, Belgium
, Walthère DewéGSK Vaccines, Rixensart, Belgium
, Christelle DurandGSK Vaccines, Wavre, Belgium
, Xavier DuvalHôpital Bichat Claude Bernard, GH BICHAT. Paris cedex 18, France; Inserm, CIC 007 for the French Network of Clinical Investigation in Vaccinology (REIVAC), Paris Cedex 18, France
, Ann R. FalseyUniversity of Rochester Medical Center, Rochester General Hospital, Rochester, NY, USA
, Gregory FeldmanCarolina Pharmaceutical Research, Spartanburg, South Carolina, United States
, Florence GaltierCHRU de Montpellier, Hôpital Saint Eloi, Montpellier, France; Inserm, CIC 1001 for the French Network of Clinical Investigation in Vaccinology (REIVAC), Montpellier, France
, Pierre GervaisQ&T Research Sherbrooke, Sherbrooke, QC, Canada
, Shinn-Jang HwangDepartment of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; National Yang-Ming University School of Medicine, Taipei, Taiwan
, Shelly McNeilQueen Elizabeth Health Sciences Centre, Dalhousie University, PCIRN, NACI, CCfV, CAIRE, QEII HSC - VG Site Infectious Diseases, Halifax, Nova Scotia, Canada
, Jan Hendrik RichardusGGD Rotterdam-Rijnmond, Rotterdam, The Netherlands
, Andrew TrofaGSK Vaccines, King of Prussia, PA, USA
, Lidia OostvogelsGSK Vaccines, Wavre, BelgiumCorrespondence[email protected]
& for the Influence65 study group show all
Pages 3043-3055
|
Received 26 Mar 2015, Accepted 28 Jul 2016, Published online: 03 Oct 2016
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.